Kush M. Parmar, M.D., Ph.D.
Chair of the BoardatEntrada Therapeutics· In proxies 2023–2025
Kush M. Parmar, M.D., Ph.D. sits on 4 public boards.
Experience
- Entrada TherapeuticsPublic company · 3 yr
- Chair of the Board2023 – Present · 3 yrStock in role -68%
- Biotechnology Innovation OrganizationPublic company · Less than 1 yr
- Director2026 – Present · Less than 1 yrNo stock prices for these years
- Azenta, Inc.Public company · 1 yr
- Director2025 – Present · 1 yrNo stock prices for these years
- Ensoma, Inc.Public company
- Director? – PresentNo stock prices for these years
- GlycoEra AGPublic company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?